mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea

mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea

Objectives Household contacts of confirmed cases of coronavirus disease 2019 (COVID-19) are exposed to a high risk of viral transmission, and secondary incidence is an important indicator of community transmission. This study analyzed the secondary attack rate and mRNA vaccine effectiveness against...

Full description

Bibliographic Details
Main Authors:	Hanul Park, Young Joon Park, Sang Eun Lee, Min Jei Lee, Hyungtae Ahn
Format:	Article
Language:	English
Published:	Korea Disease Control and Prevention Agency 2022-12-01
Series:	Osong Public Health and Research Perspectives
Subjects:	covid-19 delta variant omicron variant vaccine efficacy vaccine effectiveness against transmission
Online Access:	http://ophrp.org/upload/pdf/j-phrp-2022-0243.pdf

Similar Items

SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
by: Haifa Khemiri, et al.
Published: (2022-09-01)

Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
by: Barbara Grüne, et al.
Published: (2022-06-01)

Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service
by: N. Radhakrishnan, et al.
Published: (2023-10-01)

Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants
by: Dominik Nörz, et al.
Published: (2022-03-01)

SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant
by: Jessica Taytard, et al.
Published: (2022-06-01)

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
by: Manish Dhawan, et al.
Published: (2022-11-01)

Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study
by: Jacek Skarbinski, et al.
Published: (2022-08-01)

Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression
by: Nando Reza Pratama, et al.
Published: (2022-12-01)

Differential Outcomes of Infection by Wild-Type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 Variants of Concern in K18-hACE2 Transgenic Mice
by: Yicheng He, et al.
Published: (2023-12-01)

The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic
by: HyokJu Ri, et al.
Published: (2022-03-01)

First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador
by: A. Carrazco-Montalvo, et al.
Published: (2022-01-01)

SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
by: Zeinab Mohseni Afshar, et al.
Published: (2023-02-01)

Clinical Characteristics of Children Infected with SARS-CoV-2 Omicron (B.1.1.529) in China’s Shanghai
by: Shu J, et al.
Published: (2024-01-01)

Genome sequencing reveals existence of SARS-CoV-2 B.1.1.529 variant in Egypt
by: Ghada Ismail, et al.
Published: (2022-05-01)

COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
by: Camilla Mattiuzzi, et al.
Published: (2022-05-01)

A study on the effect of natural products against the transmission of B.1.1.529 Omicron
by: Samar Sami Alkafaas, et al.
Published: (2023-08-01)

Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera
by: Wenhao Zhou, et al.
Published: (2022-02-01)

The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence
by: Irma Salimović-Bešić, et al.
Published: (2022-12-01)

Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing
by: Souheil Zayet, et al.
Published: (2022-11-01)

Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay
by: Chiara Ippoliti, et al.
Published: (2022-08-01)

The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals
by: Lidia Sánchez-Morales, et al.
Published: (2022-08-01)

BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages
by: Bernd Jahrsdörfer, et al.
Published: (2022-06-01)

Relationships between COVID-19 healthcare outcomes and county characteristics in the U.S. for Delta (B.1.617.2) and Omicron (B.1.1.529 and BA.1.1) variants
by: Alexander A. Bruckhaus, et al.
Published: (2023-11-01)

SARS-CoV-2 Omicron (B.1.1.529) Infection of Wild White-Tailed Deer in New York City
by: Kurt J. Vandegrift, et al.
Published: (2022-12-01)

Recent update on treatment and preventive modalities for COVID-19 Omicron variant (B.1.1.529) in India: A comprehensive review
by: Deep Inder, et al.
Published: (2022-01-01)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2022-09-01)

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
by: Camino Trobajo-Sanmartín, et al.
Published: (2022-04-01)

Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
by: Wenlin Ren, et al.
Published: (2023-04-01)

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
by: Ka-Wa Khong, et al.
Published: (2022-01-01)

The effectiveness of Paxlovid treatment in long-term care facilities in South Korea during the outbreak of the Omicron variant of SARS-CoV-2
by: Hanul Park, et al.
Published: (2022-12-01)

Computed Tomographic Imaging Features of COVID-19 Pneumonia Caused by the Delta (B.1.617.2) and Omicron (B.1.1.529) Variant in a German Nested Cohort Pilot Study Group
by: Esther Askani, et al.
Published: (2022-09-01)

COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods
by: Syed Mahfuz Al Hasan, et al.
Published: (2022-07-01)

Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation
by: Gianpaolo Marcacci, et al.
Published: (2022-08-01)

Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination
by: Dickson S., et al.
Published: (2022-12-01)

SARS-CoV-2 Omicron (B.1.1.529) variant: structural features, biological characteristics, impact on scientific research, general precautions and protective procedures; a systematic review
by: Prithiviraj Nagarajan, et al.
Published: (2022-10-01)

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United KingdomResearch in context
by: Catherine Hyams, et al.
Published: (2023-02-01)

A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
by: Hassen Mohammed, et al.
Published: (2023-01-01)

The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
by: Jéssica Pires Farias, et al.
Published: (2023-12-01)

Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)
by: Ward, IL, et al.
Published: (2022)

Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis
by: Rashidul Alam Mahumud, et al.
Published: (2022-02-01)